GAMA, L.G. and CABO, C.J. 2025. Safety profile of Trastuzumab deruxtecan in patients with advanced HER2+ breast cancer: an active pharmacovigilance study. Journal of Hospital Pharmacy and Health Services. 16, 2 (Jun. 2025), e1259. DOI:https://doi.org/10.30968/jhphs.2025.162.1259.